Morgan Stanley Investment Management Inc - Net Worth and Insider Trading
Morgan Stanley Investment Management Inc Net Worth
The estimated net worth of Morgan Stanley Investment Management Inc is at least $81 Million dollars as of 2024-11-08. Morgan Stanley Investment Management Inc is the 10% Owner of Sagent Pharmaceuticals Inc and owns about 3,731,293 shares of Sagent Pharmaceuticals Inc (SGNT) stock worth over $81 Million. Details can be seen in Morgan Stanley Investment Management Inc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Morgan Stanley Investment Management Inc has not made any transactions after 2013-10-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Morgan Stanley Investment Management Inc
Morgan Stanley Investment Management Inc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Morgan Stanley Investment Management Inc owns 6 companies in total, including Sagent Pharmaceuticals Inc (SGNT) , Morgan Stanley Emerging Markets Fund Inc (MSF) , and Latin American Discovery Fund Inc (LDF) among others .
Insider Ownership Summary of Morgan Stanley Investment Management Inc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SGNT | Sagent Pharmaceuticals Inc | 2015-01-26 | 10 percent owner |
MSF | Morgan Stanley Emerging Markets Fund Inc | 2004-08-03 | other: Investment Adviser |
LDF | Latin American Discovery Fund Inc | 2004-08-03 | other: Investment Adviser |
2004-08-03 | other: Investment Adviser | ||
2004-08-03 | other: Investment Adviser | ||
2004-08-03 | other: Investment Adviser |
Morgan Stanley Investment Management Inc Latest Holdings Summary
Morgan Stanley Investment Management Inc currently owns a total of 1 stock. Morgan Stanley Investment Management Inc owns 3,731,293 shares of Sagent Pharmaceuticals Inc (SGNT) as of October 3, 2013, with a value of $81 Million.
Latest Holdings of Morgan Stanley Investment Management Inc
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SGNT | Sagent Pharmaceuticals Inc | 2013-10-03 | 3,731,293 | 21.76 | 81,192,936 |
Holding Weightings of Morgan Stanley Investment Management Inc
Morgan Stanley Investment Management Inc Form 4 Trading Tracker
According to the SEC Form 4 filings, Morgan Stanley Investment Management Inc has made a total of 0 transactions in Sagent Pharmaceuticals Inc (SGNT) over the past 5 years. The most-recent trade in Sagent Pharmaceuticals Inc is the sale of 47,826 shares on October 3, 2013, which brought Morgan Stanley Investment Management Inc around $969,433.
Insider Trading History of Morgan Stanley Investment Management Inc
- 1
Morgan Stanley Investment Management Inc Trading Performance
Morgan Stanley Investment Management Inc Ownership Network
Ownership Network List of Morgan Stanley Investment Management Inc
Ownership Network Relation of Morgan Stanley Investment Management Inc
Morgan Stanley Investment Management Inc Owned Company Details
What does Sagent Pharmaceuticals Inc do?
Who are the key executives at Sagent Pharmaceuticals Inc?
Morgan Stanley Investment Management Inc is the 10 percent owner of Sagent Pharmaceuticals Inc. Other key executives at Sagent Pharmaceuticals Inc include 10 percent owner Vivo Ventures V, Llc , 10 percent owner Vivo Ventures V Affiliates Fund, L.p. , and 10 percent owner Vivo Ventures Fund V, L.p. .
Sagent Pharmaceuticals Inc (SGNT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sagent Pharmaceuticals Inc (SGNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sagent Pharmaceuticals Inc (SGNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sagent Pharmaceuticals Inc (SGNT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sagent Pharmaceuticals Inc Insider Transactions
Morgan Stanley Investment Management Inc Mailing Address
Above is the net worth, insider trading, and ownership report for Morgan Stanley Investment Management Inc. You might contact Morgan Stanley Investment Management Inc via mailing address: 1221 Avenue Of Americas, New York Ny 10020.